News room
Sofia Côrte-Real on behalf of Technophage at the 6th Annual Bacteriophage Summit
Our Chief Scientific Officer and Deputy CEO, Sofia Corte-Real, will act as both the chair and a speaker at the upcoming 6th Annual Bacteriophage...
Technophage is looking for a Quality Control Manager to join the team
Technophage is currently looking for a Quality Control Manager to join our Quality and Production team. Technophage requires academic degree...
Technophage announces dosing of first patient in Phase 2b Clinical Trial for TP-102 in Diabetic Foot Ulcers
Technophage, a biopharmaceutical company specializing in the development and production of biologics, particularly bacteriophage-based products, has...
TechnoPhage starts Phase 2b study of TP-102 bacteriophage treatment for diabetic foot infections
TechnoPhage, a clinical-stage biopharmaceutical company specializing in the development of phage treatments targeting specific pathogenic bacteria,...
Technophage was recognized with ‘PME líder 2023’ distinction by IAPMEI
We are thrilled to announce that Technophage has been recognized by IAPMEI, I.P. - Agência para a Competitividade e Inovação (Agency for...